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α-Glucosidase (extinction coefficient 3.2.1.20) is a primary carbohydrate metabolizing 
enzyme that acts on the 1–4 associated α-glucose residues. The inhibition of 
α-glucosidase slows down the process of carbohydrate digestion and avoids postprandial 
hyperglycemia, which is a major cause of chronic diabetes-associated complication. 
This study was designed to evaluate the binding capacity of isolated alkaloids with 
targeted receptor. For this purpose, the three-dimensional tertiary structure of the 
α-glucosidase was generated by using the Molecular Operating Environment (MOE). 
The generated model was then validated by using the RAMPAGE and ERRAT server. The 
molecular docking of 37 alkaloids along with standard acarbose and miglitol reported as 
a α-glucosidase inhibitor was performed via MOE-Dock implemented in MOE software 
to find the binding modes of these inhibitors. The results showed that compound 17 
(oriciacridone F) and 24 (O-methylmahanine) demonstrated marked interaction with 
active residues and were comparable to standard inhibitors. In short, this study provided 
computational background to the reported α-glucosidase inhibitors and thus further 
detail studies could lead to novel effective compounds.
Keywords: α-glucosidase inhibitors, homology modeling, molecular docking, Molecular Operating environment, 
α-glucosidase
inTrODUcTiOn
α-Glucosidase is a primary carbohydrate digestive enzyme, which is present in the brush border 
of the small intestine. It has action on 1,4-α bonds and thus different from β-glucosidase (1–4)1. 
α-Glucosidase catalyzes starch and disaccharides to glucose. Maltase is a similar enzyme that acts 
upon maltose and is nearly equivalent in function to α-glucosidase. The carbohydrates need metabo-
lism by α-glucosidase before being absorbed into the small intestine. By inhibiting the α-glucosidase, 
the process of carbohydrate digestion slows down, which helps prevent postprandial hyperglycemia 
because postprandial hyperglycemia is a major cause of chronic diabetes and associated complica-
tions (5). In this regard, several research groups have been working on the desiging of new effective 
α-glucosidase inhibitors that can be used as therapeutic agents for the suppression of metabolic 
disorders such as hyperglycemia, obesity, and non-insulin-dependent type II diabetes mellitus (5).
1 http://www.bioplek.org/animaties/enzymen/maltase2.html.
Table 1 | The structure of the isolated alkaloids with docking scores.
s. no. structures Docking score(s)
1 −6.5918
2 −6.6343
3 −8.6058
4 −6.1790
5 −8.8493
6 −6.9539
(Continued )
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The therapeutic potential of alkaloids has been recognized in 
the treatment of various human disorders (6–11). The literature 
review revealed that approximately 37 isolated alkaloids have 
been tested for α-glucosidase inhibitory activity (12), as shown 
in Table  1. Gao and colleagues isolated two compounds 1–2 
from the leaves of Adhatoda vasica Nees. Both these compounds 
caused marked competitive α-glucosidase inhibition in animal 
models (13). The phytochemical studies of Campanulaceae 
s. no. structures Docking score(s)
7 −7.7617
8 −9.3806
9 −7.4514
10 −8.7862
11 −6.0582
12 −8.3342
Table 1 | continued
(Continued )
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Table 1 | continued
s. no. structures Docking score(s)
13 −8.4982
14 −11.3333
15 −6.5704
16 −10.6081
17 −15.1310
(Continued )
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Table 1 | continued
s. no. structures Docking score(s)
18 −8.2973
19 −8.0484
20 −7.3406
21 −9.4372
22 −13.6324
(Continued )
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Table 1 | continued
s. no. structures Docking score(s)
23 −11.5949
24 −14.9192
25 −10.1657
26 −8.4088
(Continued )
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Table 1 | continued
s. no. structures Docking score(s)
27 −10.4082
28 −6.2268
29 −8.4188
30
31 −7.4784
(Continued )
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Table 1 | continued
s. no. structures Docking score(s)
32 −9.5179
33 −5.8070
34 −12.1778
35 −8.9628
36 −10.5989
(Continued )
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Table 1 | continued
s. no. structures Docking score(s)
37 −10.4884
Standard −15.4423
Standard −14.7983
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Lobelia species led to the isolation of 10 compounds 4–12. 
These compounds also possessed significant anti-glucosidase 
effect (14). The potent inhibitors, deoxynojirimycin (DNJ) and 
2,5-bis(hydroxymethyl)-3,4-dihydroxypyrrolidine (DMDP) 
(14–18), were isolated from many plants. The DNJ, along 
with several other therapeutic effects, provoked outstand-
ing attenuation on glucosidase and thus clinically used as 
a zero-harm-antidiabetic drug agent. Three more alkaloids 
named piperumbellactams A–C 13–15 have been isolated 
from Piper umbellatum, produced significant α-glucosidase 
inhibition (19). Wansi et  al. isolated acridones alkaloids 
16–18, from Oriciopsis glaberrima Engl, also displayed pro-
found α-glucosidase inhibition, especially compound 17 
(oriciacridone F) with IC50:34.05  mM (20). Buthus martensii 
Karsch led to the isolation of 19, a potent non-competitive 
glucosidase inhibitor (21). Similarly, Piper sarmentosum led to 
the purification of two chaplupyrrolidones alkaloids A 20 and 
B 21, which possessed strong anti-glucosidase activity (22). 
Murraya koenigii guide to the isolation of six different alkaloids 
22–27 that caused α-glucosidase inhibition. Of the compounds, 
FigUre 1 | Target-template alignment by multiple sequence alignment server.
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FigUre 4 | superposition of target (red) and template (green).FigUre 3 | root mean square deviation of target and template.
FigUre 2 | 3D tertiary structure of target.
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O-methylmahanine 24 showed marked effect with IC50 29.1 μM 
(23). Tabussum and co-worker isolated plicatanins A–D 28–31 
alkaloids from Chrozophora plicata also caused significant 
α-glucosidase inhibition (24). Six alkaloids 32–36 with potent 
α-glucosidase inhibitory activity have been isolated from Morus 
atropurpurea (12).
The aim of this research study was to find out the interaction 
of these reported alkaloids with the target protein and thus find-
ings could be useful for the discovery of new, potent, and active 
α-glucosidase inhibitors.
MaTerials anD MeThODs
In this research studies, we have generated the three-dimensional 
structure of the glucosidase by using the Molecular Operating 
Environment (MOE) software, and molecular docking study 
was performed on the same software. The MOE-Dock was 
used as docking software implemented in MOE, and ligplot is 
implemented in MOE for the purpose to visualize the interaction 
between protein and ligand.
retrieval of the Target sequence
The primary sequence of the α-glucosidase of Saccharomyces 
cerevisiae (Baker’s yeast) was retrieved using Uniprot (Universal 
Protein Resource)2 in FASTAformat, and the target sequence was 
then kept in the text file for further evaluation. The accession 
number of α-glucosidase of S. cerevisiae is P07265.
Template selection
The target sequence of α-glucosidase was downloaded from the 
Universal Protein Resource (uniprot dataset). Then, Protein-
BLAST (25) was done to identify homologs in the PDB (RCSB 
Protein Databank) (26). Hence, the crystal structure of Isomaltase 
from the S. cerevisiae (Pdb Id: 3A47−A), which has 72% sequence 
identity to the target protein, was selected as the template for the 
target protein sequence for the prediction of the tertiary structure 
of target protein.
alignment of the Target-Template 
sequence
For the sequence alignment of the target protein, α-glucosidase 
and template protein (PDB ID: 3A47−A), multiple sequence 
alignment (MUSCLE) was employed (27) server.3 The ClustalW 
program from the MUSCLE server was used for the alignment of 
the target-template sequence.
homology Modeling
The amino acid sequence of the target protein in FASTA 
format was copied and paste in the sequence editor of the 
2 http://www.uniprot.org/.
3 http://www.ebi.ac.uk/Tools/msa/muscle/.
FigUre 5 | ramachandran maps of α-glucosidase produced by raMPage. Light orange and light blue are allowed regions, while dark orange and dark blue 
are favored regions.
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MOE software. Then, the template protein was loaded in the 
same MOE software. The chain 1 showed the target protein 
sequence, and chain 2 showed the template protein sequence. 
The target and template sequences were aligned before start-
ing the homology modeling and calculated the root mean 
square deviation (RMSD) with the template. In model refin-
ing tool, the intermediate was set to medium, final model 
to medium, by means of scoring function generalized born/
volume integral (GB/VI). Amber 99 with Solvation RField 
was used as a force field. Various 10 models were formulated, 
while the final refine model was introduced to MOE main 
window.
Validation of Modeled structure
The overall geometric and stereochemical qualities of the final 
model were examined using RAMPAGE and ERRAT server 
(28, 29). ERRAT server was used to check the quality.
active site Prediction
The α-glucosidase protein active sites were studied by means of 
the “MOE-Site Finder” Module, which computes the possible 
recognition sites from the 3D atomic coordinates of the protein. 
The Site Finder module is considered a geometric method, as 
energy models were not utilized. Rather, the relative positions 
and accessibility of the protein atoms were targeted followed by 
FigUre 6 | erraT server shows the overall quality of the α-glucosidase. *On the error axis, two lines are drawn to indicate the confidence with which it is 
possible to reject regions that exceed that error value. **Expressed as the percentage of the protein for which the calculated error value falls below the 95% 
rejection limit. Good high resolution structures generally produce values around 95% or higher. For lower resolutions (2.5–3 A), the average overall quality factor is 
around 91%.
FigUre 7 | Predicted binding pocket of α-glucosidase by mean of 
Molecular Operating environment site Finder.
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a rough classification of chemical types. Once these regions were 
calculated, dummy atoms were assigned to these sites and later 
used to make the molecular docking calculation for specified 
sites.
ligand Preparation
The compounds included in our study were all collected from 
reported literature (12, 23). All these compounds were gener-
ated by using the Chembio-Office 2010–2012 and then all these 
compounds were saved in mol file for the purpose to open these 
files in MOE and were energy minimized via MOE using default 
parameters.
Protein Preparation
The modeled structure of the target protein was 3D protonated 
and then energy minimization was performed by using the MOE 
software with default parameters.
Molecular Docking
Molecular docking was performed via MOE-dock with most of 
the default tools with the aim to find the binding interaction of 
the ligand with the target protein. Ligand was docked into the 
target site of predicted homology model of the α-glucosidase 
by mean of MOE-Dock module (v.2011.10), for each ligand 10 
conformations were generated. The top-ranked conformation of 
each ligand was used for detailed study of binding mode.
resUlTs
calculation of Physiochemical Properties
For calculating the physiochemical properties, we used the 
Expasy-ProtParam server tool. The protein has 584 numbers of 
amino acids, and its estimated molecular weight was 68,183.3 Da 
and Theoretical pI: 5.53. The extinction coefficient (EC) of the 
predicted model was 148,990 at 280 nm, which indicated that at a 
specific wavelength, how much light was absorbed, EC is in units 
of m cm−1, measured in water at 280 nm. The instability index (II) 
was computed to be 30.07, which showed the protein was stable. 
The II more than 40 rated protein as not stable. The hydrophilic 
character was calculated by the grand average of the hydropathy 
index value of −0.676, and the aliphatic index was calculated to 
be 64.28.
Target-Template alignment
The MUSCLE server was used for the determination of the 
alignment of the query sequence to the template. The alignment 
was made in order for the development of a resulting model. The 
configuration is presented in Figure 1. In the figure, (*) symbol 
represents the single entire conserved residues, (-) symbol rep-
resents the deleted regions, and (:) and (:) symbols represent 
14
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FigUre 10 | 3D interaction of compound 37.
FigUre 11 | Docked conformation of compound 33 with receptor.
the conservation of strong and weak groups correspondingly. 
Finally, from the evaluation of the results of target-template 
alignment, it was found that there is sequence homology 
between α-glucosidase and crystal structure of Isomaltase from 
S. cerevisiae 3A47–A.
homology Modeling
For 3D structure modeling, MOE software (MOE 2010–2011) 
was employed, while used relative protein structure modeling in 
the following way.
(1) MOE docked the initial partial geometry of target sequence 
using template structure and used to preserved residue identity.
(2) The residues without specific backbone coordinates were 
characterized via a specific logic insertions and deletions 
treatment (30).
(3) First, a random order was used for loops modeling. A file 
of probable candidates were scrutinized using contact 
energy function based on Boltzmann weighted averaging 
(31, 32).
Model was developed while using various tools such as Model 
Scoring to GB/VI test (33). Force fields to Amber99 used in MOE 
suggested for protein homology purposes (34). Subsequent to 
homology modeling, the force field AMBER99 was used to mini-
mize the energy of target structure to 0.05 G and this specifically 
characterized proteins and nucleic acids. The PDB format was 
used for resulting structure (Figure  2) having an appropriate 
identity. The model proposed was superimposed on template 
structure holding RMSD of 0.639 observing close homology 
(Figure  3) using the MOE software. The superposition of the 
target and template are shown in Figure 4.
Validation of Modeled structure
RAMPAGE server explained the stereochemical characters 
of the 3D structure. Stereochemical evaluation of backbone 
Phi and Psi dihedral angles (35) is shown in Figure 5. Besides, 
Ramachandran plot analysis showed that 83.8% components were 
in the favored region, 10.3% residue in the permissible region, 
while 5.8% residues in the outlier regions of Ramachandran plot, 
which indicated that the proposed model is reliable for further 
FigUre 8 | 3D interaction image of most active ligand 17.
FigUre 9 | 3D-binding mode of compound 24 with target.
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studies. The ERRAT server explained the statistics of non-bonded 
interaction between different atoms, and a score of 50 was gener-
ally suitable and for the 3D structure evaluation, the predicted 
model had quality score 79.167, which indicated that the model 
was reliable and stable, as shown in Figure 6.
active site residues
The Site-Finder Module was utilized for prediction of the ligand-
binding site in the predicted model of α-glucosidase showed that 
GLN66, MET69, ASP106, ILE109, ASN152, ASN153, TRP154, 
LYS155, SER156, PHE157, PHE158, LEU174, ARG175, ARG212, 
ILE213, THR215, ALA216, PRO226, ILE230, LYS233, LYS236, 
LEU237, GLN238, HIS239, TRP242, VAL274, GLU276, VAL277, 
PHE300, VAL303, GLU304, THR307, SER308, PRO309, 
PHE310, PHE311, ARG312, TYR313, ASN347, ASP349, 
GLN350, ASP408, ASN412, LEU437, and ARG439 were found 
in the binding site of the predicted model of the α-glucosidase, 
as shown in Figure 7.
binding interaction of ligands with Target 
receptor
In our research studies, we used the 37 known alkaloid inhibi-
tor of α-glucosidase from the previous literature. These known 
alkaloid inhibitors were tested and proved experimentally from 
FigUre 12 | The figure shows the 2D images of the docked conformations of the ligands with the active residues (a) 2D image of compound 17, (b) 
2D image of compound 24, (c) 2D image of compound 37, and (D) 2D image of compound 33.
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the previous literature (12, 23). In the present research work, we 
found out the binding interaction and docking scores of these 
selected compounds with the target protein by molecular docking, 
as shown in Table 1. These results might be beneficial in the drug 
designing of the novel and potent inhibitors of the glucosidase.
DiscUssiOn
Compound 17 and compound 24 showed the best docking score 
i.e., −15.1310 and −14.9192, respectively, among the 37 differ-
ent alkaloids, and these compounds have good inhibition and 
docking score nearly similar relative to the reference (standard) 
ligands, miglitol (−15.4423) and acarbose (−14.7983). These two 
compounds are most active and showed good interaction with 
the target protein.
Compound 17, the most active ligand, formed three hydrogen 
bonds, one hydrophobic interaction, and one arene cation inter-
action with the Asn153, Arg312, Glu304, Trp154, and Lys155 
active amino acid residues, respectively. Lys155 formed an arene 
cation interaction with the benzene ring of the phenol moiety of 
the ligand. Glu304 was observed making a hydrogen bond with 
the hydrogen atom of the OH group of another phenol group 
of the same ligand. Arg312 and Asn153 formed hydrogen bonds 
with the oxygen atom double bonded with the piperidine moiety 
of the ligand and oxygen atom of −OH moiety of the phenol 
of dihydroxy-3,3-dimethyl-1,2,3,4-tetrahydrobenzo[c]acridin-
7(12H)-one, respectively, of the same inhibitor. Trp154 showed 
a hydrophobic interaction with the H atom of the −OH group of 
the dihydroxy-3,3-dimethyl-1,2,3,4-tetrahydrobenzo[c]acridin-
7(12H)-one moiety. The 3D interaction of the ligand with receptor 
was shown in Figure 8. Similarly, these results were in absoulte 
agreement with the in vitro α-glucisade inhibitory activity already 
reported. Moreover, it also caused marked free radical scaveng-
ing effect (20). Compound 24 is the second most active ligand 
and interacted with the Asn153 and Lys233 and was observed 
making three hydrogen bonds. Asn153 formed H-bonds with the 
hydrogen atom of OH group and with the oxygen atom of another 
−OH group of the same ligand. Lys233 was observed making an 
H-bond (hydrogen bond) with the −O atom (oxygen atom) of 
the hydroxyl moiety of the inhibitor, as shown in Figure 9. The 
docking results are consistant with the in vitro α-glucisade inhibi-
tory activity already reported, agumented by its comprehensive 
antioxidant effects (23).
Compound 37 has moderate good docking score −10.4884 
and have the best interaction with active residues. It formed five 
hydrogen bonds with the Asn153, Lys155, Lys233, Glu276, and 
Asn347, a hydrophobic interaction with the Asp349 and arene 
cation interaction with the Arg312. Arg312 made an arene cation 
interaction with the phenylene moiety of the ligand. Lys155 and 
Glu276 formed hydrogen bonds with the oxygen atom and hydro-
gen atom of the butane-1-ol. Asn153, Asn347, and Lys233 formed 
hydrogen bond interactions with the oxygen atom of the hydroxyl 
group (−OH) of the butane-4-ol. Asp349 formed ahydrophobic 
interaction with the hydrogen atom of the −OH group of the 
butane-2-ol moiety of 1,1′-(1,4-phenylene)-bis(butane-1,2,3,4-
tetraol) shown in Figure 10.
Compound 33 had low docking score −5.8070 and showed a 
low number of interaction with the active residues, i.e., formed 
one hydrogen bond and one hydrophobic interaction with the 
Lys155, as given in Figure  11. Lys155 made a hydrogen bond 
with the oxygen atom of OH group, and Lys155 interacted with 
the hydrogen atom of another −OH moiety of the (2R,3R,4R)-
2-(hydroxymethyl)piperidine-3,4-diol. Figure  12 showed the 
two-dimensional interaction images of the compounds with the 
target protein.
cOnclUsiOn
The molecular docking was made to recognize the binding 
interactions of these reported compounds with the receptor. 
We examined the interaction of inhibitors to that of our target 
receptor. The molecular docking study indicates good docking 
score and binding mode and thus showed therapeutic potential 
of these compounds on α-glucosidase inhibition. Compound 17 
(oriciacridone F) and 24 (O-methylmahanine) demonstrated 
marked interaction with active site residues, which are also cor-
related with the reported IC50 values and, thus, might be the best 
candidates for the discovery of novel α-glucosidase inhibitors, 
after in vivo efficacy, safety, and clinical studies.
Moreover, the rest of alkaloids with good receptor interaction 
could be lead compounds and therefore need further studies in 
terms of synthesis, structural relationship activity followed by 
testing in various in vitro and in vivo testing.
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